|
| | 
|
 | |
        
|  |
|  |
|
 Gilead Sciences - [Ticker: GILD] |     | | Last Trade | 71.55 | Last Trade Time | 2018-12-03 - 00:00:00 | | Variation | --0.39 (+0.99%) | Open | 72.74 | | High | 72.90 | Low | 71.52 | | Volume | 2,159,096 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 74.80 x 800 - 74.82 x 1,000 | | Former Close | 71.94 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about Gilead Sciences: | | No topics about Gilead Sciences [GILD] have been found, but a search on the Forum for more topics related to Gilead Sciences is advised. |
|
News about Gilead Sciences [GILD]: (ordered by relevance)
| - Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing Gilead Sciences
- Gilead names new manufacturing head in wake of recent hiccups FiercePharma
- Gilead Pharmaceutical Development, Manufacturing Exec Yang to Retire >GILD MarketWatch
- GILEAD SCIENCES APPOINTS DUSTIN HAINES AS NEW LEADER FOR ASIA 5 REGION The Korea Herald
2022-06-27 | NDAQ:GILD | Press Release | Gilead Sciences Inc. Stockhouse
Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress? 2022 Gilead Sciences
Gilead Sciences: Buy The Dip (NASDAQ:GILD) Seeking Alpha
Westminster Drug Project and Gilead Sciences join forces to take on hepatitis C PharmaTimes
All Magrolimab Studies Re-Opening for Enrollment in US | Gilead Gilead Sciences
Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV Gilead Sciences
Treatment With Hepcludex® (Bulevirtide) Meets Primary Endpoint and Achieves Significant Response in Chronic Hepatitis Delta Virus at 48 Weeks Gilead Sciences
CSRWire - Gilead Sciences Inaugural Data Science Symposium CSRwire.com
Gilead Stock: Future In Three Molecules (NASDAQ:GILD) Seeking Alpha
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity Gilead Sciences
Do Traders Think Gilead Sciences, Inc. (GILD) Can Keep Climbing Wednesday? InvestorsObserver
Gilead wins suit over patient assistance program's 'colossal financial fraud' STAT
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Raised by CAPROCK Group Inc. Defense World
Takeda Pharmaceutical Vs. Gilead Sciences: Which Stock Is The Dividend King? Seeking Alpha
Gilead Sciences is a Finalist for the PinkNews Awards in the Business Equality Category Yahoo Finance
Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Goldman Sachs Global Healthcare Conference (Transcript) Seeking Alpha
Gilead: CAR-T future is both auto and allo - Bioprocess Insider BioProcess Insider
Gilead Sciences, Inc. (GILD) Management presents at Bernstein 38th Annual Strategic Decisions Conference - Transcript Seeking Alpha
Gilead Breast-Cancer Drug Delays Progression by 1.5 Months Bloomberg
Gilead Sciences, Inc. (GILD) Management Presents at Jefferies Global Healthcare Conference - (Transcript) Seeking Alpha
Gilead Sciences Inc. stock falls Thursday, underperforms market MarketWatch
Gilead Sciences goes ex-dividend tomorrow Seeking Alpha
Gilead launches domestic products to local market Hurriyet Daily News
HGH Biosimilars Consumption Market Size And Forecast to 2028 |Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma ? Designer Women Designer Women
Providing Support for Women with Breast Cancer Gilead Sciences
ASCO: Can Gilead, Pfizer and AZ-Daiichi change breast cancer? FiercePharma
GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION Yahoo Finance
Bristol Myers' Breyanzi wins broader FDA approval to challenge Gilead's CAR-T FiercePharma
Gilead Sciences (GILD) Stock Moves -0.72%: What You Should Know Nasdaq
ViiV, Gilead and Janssen notch top scores with HIV/AIDS groups FiercePharma
Atrial Fibrillation Drugs Market Size, Scope and Forecast | ARCA Biopharma, Baxter International Inc., Bristol-Myers Squibb, Gilead Sciences, HUYA Biosciences, Janssen Pharmaceuticals, Pfizer Inc., Pierre Fabre, Servier, Xention Ltd. ? Designer Women Designer Women
Gilead Sciences expands regional footprint with new Dubai office ZAWYA
Red Biotechnology Market Size, Scope and Forecast | Amgen Inc., F. Hoffmann-La Roche, Gilead Sciences Inc., CSL, Pfizer Inc. ? Designer Women Designer Women
Veriti Management LLC Has $897000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD) Defense World
Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of ?Hold? by Brokerages Defense World
PD-1 And PD-L1 Inhibitors Market Size, Scope and Forecast | Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene ? Designer Women Designer Women
Gilead Joining the Global Access to Oncology Medicines Coalition Yahoo Finance
Head to Head Contrast: Surrozen (NASDAQ:SRZN) vs. Gilead Sciences (NASDAQ:GILD) Defense World
Anti-Infective Drugs Market Size, Scope and Forecast | Gilead Sciences GlaxoSmithKline plc, Pfizer Novartis AG, Merck, Bayer AG, Others. ? Designer Women Designer Women
2 Beaten-Down Dividend Stocks That Are Now Yielding 5% The Motley Fool
Gene Therapy Market Size, Scope and Forecast | Novartis AG, Biogen, Gilead Sciences MolMed SpA, Spark Therapeutics Orchard Therapeutics plc., SIBIONO, Bluebird bio Shanghai Sunway Biotech Co. Ltd., Human Stem Cells Institute. ? Designer Women Designer Women
HIV Vaccines Market Size, Scope and Forecast | VIIV healthcare, Gilead Sciences, Inc, GlaxoSmithKline plc, Merck Sharp & Dohme Corp., AbbVie Inc, Mylan NV, and many more. ? Designer Women Designer Women
Chemical Medication in COVID-19 Market is Thriving worldwide by 2029| Top Key Players Gilead Sciences, AbbVie, Johnson and Johnson ? Designer Women Designer Women
Compensated Cirrhosis Type C Market Research With Gilead Sciences, AbbVie, Novartis International, Intercept Pharmaceuticals, Novo Nordisk A/S | 2022 Report ? Indian Defence News Indian Defence News
7 Biotech Stocks With Key Catalysts Coming in July InvestorPlace
Gilead Sciences Announces First Quarter 2022 Financial Results Gilead Sciences
Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results Gilead Sciences
3 Top Dividend Stocks for Generating Passive Income The Motley Fool
Hypertension Drug Market Size, Share, SWOT Analysis, Growth & Forecast by 2030 Digital Journal
Cerium Oxide Nanoparticles Market Incredible Possibilities, Growth with Industry Study, Detailed Analysis and Forecast ? Designer Women Designer Women
Gilead Sciences to Release First Quarter 2022 Financial Results on Thursday, April 28, 2022 Gilead Sciences
X-Ray Devices and Accessories Market by 2029 | Abbvie Inc., Gilead Sciences Inc., Merck and Co. ? Indian Defence News Indian Defence News
Gilead Sciences to Present at Upcoming Investor Conferences Gilead Sciences
Gilead Sciences Announces 2.8 Percent Increase in First Quarter 2022 Dividend Gilead Sciences
Small Molecule Sterile Injectable Drugs Market Research With Gilead Sciences, Inc., BIOCRYST PHARMACEUTICALS | Outlook, Growth By Top Companies, Regions, Trends and Forecasts by 2022 to 2026 ? Indian Defence News Indian Defence News
Cystic Fibrosis Therapeutics Market Size, Status, Recent Trends and Future Scope Analysis to 2027- Vertex Pharmaceuticals, F. Hoffmann-La Roche ? Designer Women Designer Women
Global Dental Vacuum Pumps Market Global Opportunity Analysis |Industry Forecast 2022-2029 | Pfizer, Gilead Sciences, Johnson & Johnson ? Designer Women Designer Women
Gilead Receives Complete Response Letter From US FDA for Investigational Lenacapavir Due to Vial Compatibility Issues Gilead Sciences
Systemic Scleroderma Treatment Market Insights, Forecast to 2030| Boehringer Ingelheim International GmbH, Novartis AG, Gilead Sciences Inc. Digital Journal
Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report Gilead Sciences
Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere Gilead Sciences
Liposome Drug Delivery Market Size 2022 -2029 | Gilead Sciences, Novartis, Pacira, Johnson & Johnson ? Indian Defence News Indian Defence News
Global Inflammatory Bowel Disease Treatment Industry to 2028 ? Key Drivers, Challenges and Trends by Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc, Alkem Laboratories Limited ? Designer Women Designer Women
Roche challenges CAR-T with bispecific blood cancer approval FiercePharma
Parkinsons Disease Drugs Consumption Market Size And Forecast to 2028 |Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma ? Designer Women Designer Women
Liver Diseases Therapeutics Market will generate new growth opportunities 2022-2028 | Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, Glaxosmithkline Plc, F. Hoffmann-La Roche Ltd Digital Journal
Antifungal Drugs Market Size, Scope and Forecast | Astellas Pharma Inc., Kramer Laboratories, Pfizer Inc., GlaxoSmithKline plc., Gilead Sciences Basilea Pharmaceutica Ltd. ? Designer Women Designer Women
Adoptive Cell Therapy Market to See Booming at a CAGR of 21.5% by 2030 Future Scope with Novartis AG, Gilead Sciences, Castle Creek Biosciences, Lineage Cell Therapeutics Medgadget
Liver Diseases Therapeutics Market Size, Scope and Forecast | Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Novartis AG, Alnylam Pharmaceuticals Protagonist Therapeuti Designer Women
Global Cancer Treatment Drugs Market 2022 Latest Innovations ? Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen ? Designer Women Designer Women
FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV Gilead Sciences
Global HIV Diagnosis Industry to 2028 ? Key Drivers, Challenges and Trends by Alere Inc., Abbott Healthcare, Abbvie Inc., Bristol-Myers Squibb, Janssen Therapeutics ? Designer Women Designer Women
Zika Vaccines Market Size, Scope and Forecast | Inovio Pharmaceuticals Emergent BioSolutions Inc., Gilead Sciences Inc., Precigen LUMOS PHARMA, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Bharat Biotec Designer Women
Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis and Industry Forecast 2022-2029 | GENFIT SA, Gilead Sciences, AstraZeneca, Novartis AG ? Designer Women Designer Women
Gilead Statement on WHO Recommendation of Veklury® (Remdesivir) and Acceleration of Prequalification Submission Gilead Sciences
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation Gilead Sciences
Gilead Announces Global Resolution of Bictegravir Patent Dispute with ViiV Healthcare Gilead Sciences
Gilead and Kite Oncology to Highlight Advances Supporting New Innovations in Cancer Care at the ASCO Annual Meeting Gilead Sciences
AstraZeneca launches first COVID drug DTC ad with Evusheld FiercePharma
Is Gilead Sciences Too Dependent On These 2 Areas of Its Business? The Motley Fool
Gilead Sciences opens new drug development hub in Dublin PharmaTimes
Kite Receives US FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland Gilead Sciences
Respiratory Syncytial Virus Rsv Diagnostics Market 2022 New Tech Developments ?| Roche, Gilead Sciences, AbbVie ? Indian Defence News Indian Defence News
Huge demand of Warts Therapeutics Market by 2029 | Gilead Sciences, Inc., Sanofi ? Indian Defence News Indian Defence News
On HIV Testing Day in Louisiana, stigma remains obstacle to testing to reduce disease rate The Advocate
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters FiercePharma
Veklury® (Remdesivir) Retains Antiviral Activity Against Omicron, Delta and Other Emergent SARS-CoV-2 Variants in Multiple In Vitro Studies Gilead Sciences
Gilead to Expand Footprint in Oceanside Gilead Sciences
Sterile Injections Compounding Pharmacy Market Sales Statistics, Future Growth, Emerging Trends to 2032 | Johnson & Johnson Merck & Co., GlaxoSmithKline, Gilead Sciences ? Indian Defence News Indian Defence News
Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs Gilead Sciences
2 Red Flags for Gilead Sciences' Future The Motley Fool
Antiviral Therapy Drug Market Size, Development, Key Opportunity, Application & Forecast to 2030 ? Designer Women Designer Women
FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies Gilead Sciences
Gilead Sciences states COVID antiviral Veklury performs better the earlier its administered FiercePharma
Providing Health and Wellness Support for Women in Chicago CSRwire.com
ESG Goals | Gilead Gilead Sciences
Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study Medscape
Gilead Implements Contract Pharmacy Integrity Initiative for Branded Hepatitis C Products Gilead Sciences
Gilead Sciences joins the ABPI The Association of the British Pharmaceutical Industry
| For more news about Gilead Sciences click here:
Gilead Sciences News |
|
Website Width:
Background image: |
|  | |
|
|
![Gilead Sciences - [Ticker: GILD] chart](http://www.tr4der.com/chart/tr4der-GILD-1-year.png)
